CymitQuimica logo

Rilapladib

CAS:

Ref. 3D-FR104267

1g
Discontinued
2g
Discontinued
25mg
Discontinued
50mg
Discontinued
100mg
Discontinued
250mg
Discontinued
500mg
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

Rilapladib
Biosynth

    Product Information

    Name:Rilapladib
    Brand:Biosynth
    Description:Rilapladib is an inhibitor of the class of lipoprotein-associated phospholipase A2 (LpPLA2) that has a potent inhibitory effect on the synthesis of pro-inflammatory and pro-thrombotic mediators. Rilapladib is a lipid-lowering drug that inhibits LpPLA2, which is involved in the production of inflammatory and thrombotic mediators. The clinical efficacy and safety of rilapladib has been studied in patients with coronary artery disease who are at risk for cardiovascular events. Results from these studies reveal that rilapladib can reduce the risk of cardiovascular events.
    Notice:Our products are intended for lab use only. For any other use, please contact us.

    Chemical properties

    Molecular weight:735.81 g/mol
    Formula:C40H38F5N3O3S
    Purity:Min. 95%
    Color/Form:Powder

    Inquiry about discontinued product: Rilapladib

    ◻️
    CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
    * Mandatory fields.